Nipon Chattipakorn Selected Research

Nipon Chattipakorn Research Topics

Disease

83	Mitochondrial Diseases (Mitochondrial Disease) 10/2022 - 05/2011
69	Insulin Resistance 10/2022 - 03/2011
62	Inflammation (Inflammations) 10/2022 - 05/2011
43	Reperfusion Injury 05/2022 - 07/2008
39	Obesity 06/2022 - 07/2009
38	Iron Overload 01/2022 - 04/2009
36	Ischemia 08/2022 - 07/2008
34	Cognitive Dysfunction 06/2022 - 10/2014
33	Infarction (Infarctions) 05/2022 - 08/2011
24	Cardiac Arrhythmias (Arrythmia) 05/2022 - 03/2006
20	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 01/2005
20	Left Ventricular Dysfunction 05/2022 - 10/2011
19	Heart Failure 08/2022 - 09/2006
19	Cardiomyopathies (Cardiomyopathy) 06/2022 - 04/2009
18	Myocardial Infarction 10/2021 - 07/2007
17	Neoplasms (Cancer) 10/2022 - 02/2015
17	Body Weight (Weight, Body) 06/2021 - 07/2009
15	Thalassemia 04/2021 - 02/2011
15	Ventricular Fibrillation 01/2020 - 05/2003
14	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 07/2008
14	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2011
11	Fibrosis (Cirrhosis) 08/2022 - 06/2015
10	Cardiotoxicity 01/2022 - 01/2020
10	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2007
10	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2015
9	Dysbiosis 01/2022 - 01/2017
7	Prediabetic State (Prediabetes) 10/2022 - 10/2018
7	Neuroinflammatory Diseases 10/2022 - 01/2021
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 04/2008
5	Osteoporosis 02/2022 - 02/2016
5	Pain (Aches) 02/2022 - 04/2018
5	Anemia 01/2021 - 01/2016
5	Hyperglycemia 01/2021 - 08/2017
4	Encephalitis (Encephalitis, Rasmussen) 08/2022 - 01/2016
4	Atrial Fibrillation 01/2022 - 02/2016
4	Sepsis (Septicemia) 12/2021 - 12/2016
4	Heart Diseases (Heart Disease) 11/2021 - 05/2011
4	Infections 11/2021 - 04/2008
4	Brain Ischemia (Cerebral Ischemia) 08/2021 - 11/2020
4	Stroke (Strokes) 11/2020 - 01/2019
3	Chemotherapy-Related Cognitive Impairment 10/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

55	Insulin (Novolin)FDA Link 06/2022 - 03/2011
36	IronIBA 01/2022 - 04/2009
25	Proteins (Proteins, Gene)FDA Link 06/2022 - 09/2006
25	Metformin (Glucophage)FDA LinkGeneric 06/2022 - 08/2012
22	VildagliptinIBA 01/2019 - 08/2012
18	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2009
18	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 05/2011
16	Testosterone (Sustanon)FDA Link 12/2020 - 01/2015
15	Biomarkers (Surrogate Marker)IBA 05/2022 - 12/2016
15	Estrogens (Estrogen)FDA Link 01/2022 - 11/2011
14	salicylhydroxamic acid (SHAM)IBA 08/2022 - 12/2014
14	CytokinesIBA 05/2022 - 07/2012
13	LipidsIBA 10/2022 - 11/2015
13	Pharmaceutical PreparationsIBA 10/2022 - 02/2011
13	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2018 - 07/2013
11	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 01/2020
11	CalciumIBA 01/2022 - 02/2011
11	AntioxidantsIBA 08/2019 - 04/2008
10	Chelating AgentsIBA 01/2022 - 01/2014
10	fibroblast growth factor 21IBA 01/2021 - 11/2015
9	Transferrin (beta 2 Transferrin)IBA 01/2022 - 06/2012
8	CholesterolIBA 06/2021 - 08/2012
8	Insulin ReceptorIBA 01/2019 - 11/2011
7	dapagliflozinIBA 10/2021 - 10/2017
7	PrebioticsIBA 12/2020 - 01/2017
7	Atorvastatin (Lipitor)FDA Link 10/2020 - 01/2016
6	3- (2,4- dichloro- 5- methoxyphenyl)- 2- sulfanyl- 4(3H)- quinazolinoneIBA 06/2022 - 01/2018
6	Galactose (Galactopyranose)FDA LinkGeneric 04/2022 - 01/2018
6	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2022 - 01/2017
6	humaninIBA 01/2022 - 01/2016
6	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 10/2017
6	Amyloid beta-PeptidesIBA 01/2021 - 07/2017
6	Malondialdehyde (Propanedial)IBA 10/2020 - 06/2012
6	DeferiproneIBA 12/2019 - 01/2014
6	Indicators and Reagents (Reagents)IBA 06/2018 - 07/2007
6	Caspase 3 (Caspase-3)IBA 01/2018 - 05/2013
5	MelatoninIBA 05/2022 - 11/2018
5	SodiumIBA 01/2022 - 10/2017
5	Cysteine (L-Cysteine)FDA Link 12/2020 - 01/2014
5	Connexin 43 (Connexin43)IBA 01/2018 - 02/2013
4	p38 Mitogen-Activated Protein KinasesIBA 08/2022 - 05/2012
4	Lipocalin-2IBA 01/2022 - 01/2018
4	Neuroprotective AgentsIBA 01/2022 - 01/2018
4	Advanced Glycation End ProductsIBA 01/2022 - 11/2017
4	Donepezil (Aricept)FDA LinkGeneric 11/2021 - 01/2021
4	Cholinesterase Inhibitors (Anticholinesterases)IBA 11/2021 - 03/2007
4	Oxygen (Dioxygen)IBA 08/2021 - 10/2011
4	oxidized low density lipoproteinIBA 06/2021 - 01/2019
4	Acetylcysteine (Siran)FDA LinkGeneric 01/2020 - 01/2019
4	Isoflurophate (DFP)FDA Link 03/2018 - 01/2016
4	CreatinineIBA 01/2018 - 01/2016
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2017 - 05/2011
4	Ferritins (Ferritin)IBA 11/2016 - 08/2013
4	Rosiglitazone (Avandia)FDA Link 05/2013 - 05/2011

Therapy/Procedure

42	Therapeutics 05/2022 - 01/2005
13	Drug Therapy (Chemotherapy) 01/2022 - 03/2007
10	Vagus Nerve Stimulation 01/2022 - 11/2013
6	Blood Transfusion (Blood Transfusions) 01/2022 - 02/2011
6	Glycemic Control 10/2021 - 07/2013